CAMBRIDGE BIOPOLYMERS LIMITED

Company Registration Number:
04122748 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2017

Period of accounts

Start date: 01 January 2017

End date: 31 December 2017

Page 1

CAMBRIDGE BIOPOLYMERS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2017

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 9

Page 2

CAMBRIDGE BIOPOLYMERS LIMITED

Company Information

for the Period Ended 31 December 2017




Director: C. G. Chappell
C. S. Fitchett
N. G. Laughton
P. V. F. Beardow
J. S. Seefeld
Secretary: C. G. Chappell
Registered office: Signal House
127 Molesey Avenue
West Molesey
Surrey
KT8 2FF
Company Registration Number: 04122748 (England and Wales)

Page 3

CAMBRIDGE BIOPOLYMERS LIMITED

Directors' Report Period Ended 31 December 2017

The directors present their report with the financial statements of the company for the period ended 31 December 2017

Directors

The directors shown below have held office during the whole of the period from 01 January 2017 to 31 December 2017
C. G. Chappell
C. S. Fitchett
N. G. Laughton
P. V. F. Beardow
J. S. Seefeld

Secretary
C. G. Chappell

This report was approved by the board of directors on 8 August 2018
And Signed On Behalf Of The Board By:

Name: N. G. Laughton
Status: Director

Page 4

CAMBRIDGE BIOPOLYMERS LIMITED

Profit and Loss Account

for the Period Ended 31 December 2017


Notes
2017
£
2016
£
Gross Profit or (Loss) 6,219 10,314
Distribution Costs (0) (33)
Administrative Expenses (21,247) (27,705)
Operating Profit or (Loss) (15,028) (17,424)
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges (0) (0)
Profit or (Loss) Before Tax (15,028) (17,424)
Tax on Profit (0) (0)
Profit or (Loss) for Period (15,028) (17,424)

The notes form part of these financial statements

Page 5

CAMBRIDGE BIOPOLYMERS LIMITED

Balance sheet

As at 31 December 2017


Notes
2017
£
2016
£
Fixed assets
Intangible assets: 2 121,446 121,446
Tangible assets: 3 509 3,854
Total fixed assets: 121,955 125,300
Current assets
Stocks: 16,950 16,950
Debtors: 0 0
Cash at bank and in hand: 293 987
Total current assets: 17,243 17,937
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 17,243 17,937
Total assets less current liabilities: 139,198 143,237
Creditors: amounts falling due after more than one year: ( 1,059,829 ) ( 1,048,840 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): ( 920,631 ) ( 905,603 )

The notes form part of these financial statements

Page 6

CAMBRIDGE BIOPOLYMERS LIMITED

Balance sheet continued

As at 31 December 2017


Notes
2017
£
2016
£
Capital and reserves
Called up share capital: 270,989 270,989
Revaluation reserve: 4 0 0
Profit and loss account: ( 1,191,620 ) ( 1,176,592 )
Shareholders funds: ( 920,631 ) ( 905,603 )

For the year ending 31 December 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 8 August 2018
And Signed On Behalf Of The Board By:

Name: N. G. Laughton
Status: Director

The notes form part of these financial statements

Page 7

CAMBRIDGE BIOPOLYMERS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Page 8

CAMBRIDGE BIOPOLYMERS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

  • 2. Intangible assets

    Total
    Cost £
    At 01 January 2017 121,446
    Additions 0
    Disposals (0)
    Revaluations 0
    Transfers 0
    At 31 December 2017 121,446
    Amortisation
    Charge for year -
    On disposals -
    Other adjustments -
    Amortisation at 31 December 2017 -
    Net book value
    Net book value at 31 December 2017 121,446
    Net book value at 31 December 2016 121,446

Page 9

CAMBRIDGE BIOPOLYMERS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

3. Tangible Assets

Total
Cost £
At 01 January 2017 52,345
Additions 0
Disposals (0)
Revaluations 0
Transfers 0
At 31 December 2017 52,345
Depreciation
At 01 January 2017 48,491
Charge for year 3,345
On disposals (0)
Other adjustments 0
At 31 December 2017 51,836
Net book value
At 31 December 2017 509
At 31 December 2016 3,854

Page 10

CAMBRIDGE BIOPOLYMERS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2017

4. Revaluation reserve


2017
£
Balance at 01 January 2017 0
Surplus or deficit after revaluation 0
Balance at 31 December 2017 0

Page 11